Estimating Exposome Score for Schizophrenia Using Predictive Modeling Approach in Two Independent Samples: The Results From the EUGEI Study.


Journal

Schizophrenia bulletin
ISSN: 1745-1701
Titre abrégé: Schizophr Bull
Pays: United States
ID NLM: 0236760

Informations de publication

Date de publication:
11 09 2019
Historique:
entrez: 12 9 2019
pubmed: 12 9 2019
medline: 11 7 2020
Statut: ppublish

Résumé

Exposures constitute a dense network of the environment: exposome. Here, we argue for embracing the exposome paradigm to investigate the sum of nongenetic "risk" and show how predictive modeling approaches can be used to construct an exposome score (ES; an aggregated score of exposures) for schizophrenia. The training dataset consisted of patients with schizophrenia and controls, whereas the independent validation dataset consisted of patients, their unaffected siblings, and controls. Binary exposures were cannabis use, hearing impairment, winter birth, bullying, and emotional, physical, and sexual abuse along with physical and emotional neglect. We applied logistic regression (LR), Gaussian Naive Bayes (GNB), the least absolute shrinkage and selection operator (LASSO), and Ridge penalized classification models to the training dataset. ESs, the sum of weighted exposures based on coefficients from each model, were calculated in the validation dataset. In addition, we estimated ES based on meta-analyses and a simple sum score of exposures. Accuracy, sensitivity, specificity, area under the receiver operating characteristic, and Nagelkerke's R2 were compared. The ESMeta-analyses performed the worst, whereas the sum score and the ESGNB were worse than the ESLR that performed similar to the ESLASSO and ESRIDGE. The ESLR distinguished patients from controls (odds ratio [OR] = 1.94, P < .001), patients from siblings (OR = 1.58, P < .001), and siblings from controls (OR = 1.21, P = .001). An increase in ESLR was associated with a gradient increase of schizophrenia risk. In reference to the remaining fractions, the ESLR at top 30%, 20%, and 10% of the control distribution yielded ORs of 3.72, 3.74, and 4.77, respectively. Our findings demonstrate that predictive modeling approaches can be harnessed to evaluate the exposome.

Identifiants

pubmed: 31508804
pii: 5537033
doi: 10.1093/schbul/sbz054
pmc: PMC6737483
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

960-965

Subventions

Organisme : Medical Research Council
ID : MR/L010305/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P005748/1
Pays : United Kingdom

Investigateurs

Behrooz Z Alizadeh (BZ)
Therese van Amelsvoort (T)
Richard Bruggeman (R)
Wiepke Cahn (W)
Lieuwe de Haan (L)
Jurjen J Luykx (JJ)
Ruud van Winkel (R)
Bart P F Rutten (BPF)
Jim van Os (J)

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Références

Schizophr Bull. 2012 Jun;38(4):661-71
pubmed: 22461484
Lancet Psychiatry. 2018 Jul;5(7):591-604
pubmed: 29773478
J Clin Epidemiol. 2019 Jun;110:12-22
pubmed: 30763612
Psychol Med. 2015 Aug;45(11):2389-401
pubmed: 25804288
Nature. 2014 Jul 24;511(7510):421-7
pubmed: 25056061
Schizophr Bull. 2003;29(3):587-93
pubmed: 14609251
Neurosci Biobehav Rev. 2016 Mar;62:1-20
pubmed: 26743858
Schizophr Res. 2017 Mar;181:17-22
pubmed: 28029515
Child Abuse Negl. 2004 Jul;28(7):771-84
pubmed: 15261471
Schizophr Bull. 2018 Jun 6;44(4):710-719
pubmed: 29701807
Int J Methods Psychiatr Res. 2012 Sep;21(3):205-21
pubmed: 22419500
Psychiatr Genet. 2018 Oct;28(5):85-89
pubmed: 30160659
Psychol Med. 2016 Mar;46(4):673-81
pubmed: 26568030
Schizophr Bull. 2014 Jul;40(4):729-36
pubmed: 24860087
JAMA Psychiatry. 2018 Oct 1;75(10):985-986
pubmed: 29874362
Arch Gen Psychiatry. 2010 Feb;67(2):113-23
pubmed: 20124111
World Psychiatry. 2019 Jun;18(2):173-182
pubmed: 31059627
Nature. 2010 Nov 11;468(7321):203-12
pubmed: 21068828
Arch Gen Psychiatry. 2004 Oct;61(10):985-9
pubmed: 15466671
Child Abuse Negl. 2007 Jan;31(1):7-26
pubmed: 17224181
Acta Psychiatr Scand. 2018 Feb;137(2):88-97
pubmed: 29288491
Am J Psychiatry. 2002 Aug;159(8):1382-7
pubmed: 12153832
Environ Health. 2017 Sep 26;16(1):102
pubmed: 28950902
Schizophr Bull. 2018 Oct 17;44(6):1175-1179
pubmed: 30169883

Auteurs

Lotta-Katrin Pries (LK)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, The Netherlands.

Agustin Lage-Castellanos (A)

Department of Cognitive Neuroscience, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands.
Department of NeuroInformatics, Cuban Center for Neuroscience, Havana, Cuba.

Philippe Delespaul (P)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, The Netherlands.

Gunter Kenis (G)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, The Netherlands.

Jurjen J Luykx (JJ)

Department of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Department of Translational Neuroscience, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
GGNet Mental Health, Apeldoorn, The Netherlands.

Bochao D Lin (BD)

Department of Translational Neuroscience, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Alexander L Richards (AL)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.

Berna Akdede (B)

Department of Psychiatry, Dokuz Eylul University School of Medicine, Izmir, Turkey.

Tolga Binbay (T)

Department of Psychiatry, Dokuz Eylul University School of Medicine, Izmir, Turkey.

Vesile Altinyazar (V)

Department of Psychiatry, Faculty of Medicine, Adnan Menderes University, Aydin, Turkey.

Berna Yalinçetin (B)

Department of Neuroscience, Health Sciences Institute, Dokuz Eylul University, Izmir, Turkey.

Güvem Gümüş-Akay (G)

Ankara University Brain Research Center, Ankara, Turkey.

Burçin Cihan (B)

Department of Psychology, Middle East Technical University, Ankara, Turkey.

Haldun Soygür (H)

Turkish Federation of Schizophrenia Associations, Ankara, Turkey.

Halis Ulaş (H)

Dokuz Eylül University, Medical School, Psychiatry Department (Discharged from by statutory decree No:701 at 8th July of 2018 because of signing "Peace Petition").

Eylem Şahin Cankurtaran (EŞ)

Güven Çayyolu Healthcare Campus, Ankara, Turkey.

Semra Ulusoy Kaymak (SU)

Atatürk Research and Training Hospital Psychiatry Clinic, Ankara, Turkey.

Marina M Mihaljevic (MM)

Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Clinic for Psychiatry CCS, Belgrade, Serbia.

Sanja Andric Petrovic (SA)

Clinic for Psychiatry CCS, Belgrade, Serbia.

Tijana Mirjanic (T)

Special Hospital for Psychiatric Disorders Kovin, Kovin, Serbia.

Miguel Bernardo (M)

Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
Institut d'Investigacions Biomèdiques August Pi I Sunyer, Barcelona, Spain.
Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.

Bibiana Cabrera (B)

Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.

Julio Bobes (J)

Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Department of Psychiatry, School of Medicine, University of Oviedo, Oviedo, Spain.
Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.
Mental Health Services of Principado de Asturias, Oviedo, Spain.

Pilar A Saiz (PA)

Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Department of Psychiatry, School of Medicine, University of Oviedo, Oviedo, Spain.
Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.
Mental Health Services of Principado de Asturias, Oviedo, Spain.

María Paz García-Portilla (MP)

Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Department of Psychiatry, School of Medicine, University of Oviedo, Oviedo, Spain.
Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.
Mental Health Services of Principado de Asturias, Oviedo, Spain.

Julio Sanjuan (J)

Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Department of Psychiatry, Hospital Clínico Universitario de Valencia, School of Medicine, Universidad de Valencia, Valencia, Spain.

Eduardo J Aguilar (EJ)

Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Department of Psychiatry, Hospital Clínico Universitario de Valencia, School of Medicine, Universidad de Valencia, Valencia, Spain.

José Luis Santos (JL)

Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Department of Psychiatry, Hospital Virgen de la Luz, Cuenca, Spain.

Estela Jiménez-López (E)

Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Universidad de Castilla-La Mancha, Health and Social Research Center, Cuenca, Spain.

Manuel Arrojo (M)

Department of Psychiatry, Instituto de Investigación Sanitaria, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain.

Angel Carracedo (A)

Fundación Publica Galega de Medicina Xenómica, Universidad de Santiago de Compostela, Santiago de Compostela, Spain.

Gonzalo López (G)

Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, IiSGM, School of Medicine, Universidad Complutense, Madrid, Spain.

Javier González-Peñas (J)

Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, IiSGM, School of Medicine, Universidad Complutense, Madrid, Spain.

Mara Parellada (M)

Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, IiSGM, School of Medicine, Universidad Complutense, Madrid, Spain.

Nadja P Maric (NP)

Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Clinic for Psychiatry CCS, Belgrade, Serbia.

Cem Atbaşoğlu (C)

Department of Psychiatry, School of Medicine, Ankara University, Ankara, Turkey.

Alp Ucok (A)

Department of Psychiatry, Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Köksal Alptekin (K)

Department of Psychiatry, Dokuz Eylul University School of Medicine, Izmir, Turkey.

Meram Can Saka (MC)

Department of Psychiatry, School of Medicine, Ankara University, Ankara, Turkey.

Celso Arango (C)

Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, IiSGM, School of Medicine, Universidad Complutense, Madrid, Spain.

Michael O'Donovan (M)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.

Bart P F Rutten (BPF)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, The Netherlands.

Jim van Os (J)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, The Netherlands.
Department of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Department of Psychosis Studies, King's College London, Institute of Psychiatry, London, UK.

Sinan Guloksuz (S)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, The Netherlands.
Department of Psychiatry, Yale School of Medicine, New Haven, CT.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH